In March of 2022, pursuant to a court Order, the FDA began releasing documents submitted to it by Pfizer in connection with Pfizer’s application to the FDA for its request for Emergency Use Authorization (EUA) and, eventually, full FDA licensing and approval of a “vaccine” ostensibly designed to prevent (or reduce the risk) of infection […]